Sophora tonkinensis Alleviates Progression of Diethylnitrosamine‐Induced Hepatocellular Carcinoma in Rats via Multitarget Regulation
Biomedical Chromatography · 2026-07 · 40 (7)
DOI: 10.1002/bmc.70486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 15.05.2026. Verfasst von Zongliang Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Biological Engineering, Chengdu University, Chengdu, China. Hauptthemen laut MEDLINE: Sophora, Carcinoma, Hepatocellular, Liver Neoplasms, Plant Extracts. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project for the Prevention and Control of Newly Emerging and Re-emerging Infectious Diseases, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Sophora tonkinensis , a traditional Chinese medicine with heat‐clearing, detoxifying, and throat‐soothing properties, has shown potential in treating hepatitis, inhibiting tumors, and regulating immunity, but its active constituents and mechanisms remain unclear. We established a hepatocellular carcinoma (HCC) model in SD rats using diethylnitrosamine (DEN), with oral gavage of S. tonkinensis extract (STE) from Weeks 1 to 16, alongside model and normal control groups. Results showed that STE significantly reduced HCC incidence, reversed weight loss, decreased the number and volume of liver nodules, improved histopathological damage, and lowered serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and albumin (ALB) levels. Integrated transcriptomic (RNA‐seq) and metabolomic (LC–MS/MS) analyses revealed enrichment in arachidonic acid and glycerophospholipid metabolism. Quantitative real‐time polymerase chain reaction (qPCR) validation confirmed that STE restored hepatic lipid homeostasis and alleviated inflammation by activating the peroxisome proliferator‐activated receptor (PPAR) pathway and suppressing the IL‐17/TGF‐β axis. These findings clarify the core mechanisms of STE in preventing and treating HCC, providing a theoretical basis for its precise clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Science and Biological Engineering, Chengdu University, Chengdu, China.
- China Military Institute of Chinese Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China.
- Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
ORCID-Profile: Xiaohe Xiao, Zhaofang Bai
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project for the Prevention and Control of Newly Emerging and Re-emerging Infectious Diseases
- Beijing Natural Science Foundation
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Lu, Z., Wen, J., Li, C., Guo, Y., Huang, S., Wang, X., Chen, X., Xu, Y., Zhan, X., Xiao, X., Zhang, L., & Bai, Z. (2026). Sophora tonkinensis Alleviates Progression of Diethylnitrosamine‐Induced Hepatocellular Carcinoma in Rats via Multitarget Regulation. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70486
Vancouver
Lu Z, Wen J, Li C, Guo Y, Huang S, Wang X, et al. Sophora tonkinensis Alleviates Progression of Diethylnitrosamine‐Induced Hepatocellular Carcinoma in Rats via Multitarget Regulation. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70486
BibTeX
@article{Lu2026,
author = {Lu, Zongliang and Wen, Jincai and Li, Chengwei and Guo, Yuanyuan and Huang, Siqi and Wang, Xianling and Chen, Xiaoyan and Xu, Yingjie and Zhan, Xiaoyan and Xiao, Xiaohe and Zhang, Lele and Bai, Zhaofang},
title = {Sophora tonkinensis Alleviates Progression of Diethylnitrosamine‐Induced Hepatocellular Carcinoma in Rats via Multitarget Regulation},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {7},
doi = {10.1002/bmc.70486}
}
EUVIMED